Fifth Third Bancorp Repligen Corp Transaction History

Fifth Third Bancorp

$25.9 Billion
Q1 2025

A detailed history of Fifth Third Bancorp transactions in Repligen Corp stock. As of the latest transaction made, Fifth Third Bancorp holds 5,734 shares of RGEN stock, worth $761,876. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,734

Previous 4,267 34.38%

Holding current value

$761,876

Previous $614,000 18.73%

% of portfolio

0.0%

Previous 0.0%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 15, 2025	BUY	$127.24 - $174.24 $186,661 - $255,610	1,467 Added 34.38%	5,734 $729,000
Q4 2024 Jan 21, 2025	SELL	$123.41 - $160.92 $3,578 - $4,666	-29 Reduced 0.68%	4,267 $614,000
Q3 2024 Oct 17, 2024	BUY	$119.79 - $167.35 $143,748 - $200,820	1,200 Added 38.76%	4,296 $639,000
Q2 2024 Jul 22, 2024	BUY	$120.0 - $182.95 $22,440 - $34,211	187 Added 6.43%	3,096 $390,000
Q1 2024 Apr 23, 2024	BUY	$170.78 - $208.42 $17,590 - $21,467	103 Added 3.67%	2,909 $535,000
Q4 2023 Jan 19, 2024	BUY	$114.17 - $185.35 $62,565 - $101,571	548 Added 24.27%	2,806 $504,000
Q3 2023 Oct 31, 2023	BUY	$138.78 - $176.51 $65,781 - $83,665	474 Added 26.57%	2,258 $359,000
Q2 2023 Jul 25, 2023	BUY	$138.42 - $180.31 $151,846 - $197,800	1,097 Added 159.68%	1,784 $252,000
Q1 2023 Apr 24, 2023	BUY	$154.26 - $198.1 $43,192 - $55,468	280 Added 68.8%	687 $115,000
Q4 2022 Jan 25, 2023	BUY	$162.42 - $220.56 $2,598 - $3,528	16 Added 4.09%	407 $0
Q3 2022 Oct 25, 2022	SELL	$160.42 - $256.21 $3,850 - $6,149	-24 Reduced 5.78%	391 $73,000
Q2 2022 Aug 04, 2022	SELL	$140.68 - $188.02 $12,661 - $16,921	-90 Reduced 17.82%	415 $67,000
Q1 2022 Apr 19, 2022	BUY	$161.19 - $257.96 $2,256 - $3,611	14 Added 2.85%	505 $95,000
Q4 2021 Feb 01, 2022	SELL	$247.59 - $304.47 $2,723 - $3,349	-11 Reduced 2.19%	491 $130,000
Q3 2021 Oct 15, 2021	SELL	$194.77 - $324.21 $8,375 - $13,941	-43 Reduced 7.89%	502 $145,000
Q2 2021 Aug 06, 2021	SELL	$165.87 - $220.95 $5,971 - $7,954	-36 Reduced 6.2%	545 $109,000
Q1 2021 May 07, 2021	SELL	$180.37 - $226.26 $2,164 - $2,715	-12 Reduced 2.02%	581 $113,000
Q4 2020 Feb 16, 2021	SELL	$148.08 - $206.57 $248,626 - $346,831	-1,679 Reduced 73.9%	593 $114,000
Q3 2020 Nov 09, 2020	SELL	$122.51 - $158.27 $35,405 - $45,740	-289 Reduced 11.28%	2,272 $335,000
Q2 2020 Aug 05, 2020	SELL	$94.33 - $140.48 $107,441 - $160,006	-1,139 Reduced 30.78%	2,561 $317,000
Q1 2020 May 05, 2020	SELL	$84.96 - $109.14 $13,168 - $16,916	-155 Reduced 4.02%	3,700 $357,000
Q4 2019 Feb 14, 2020	SELL	$73.84 - $93.08 $9,230 - $11,635	-125 Reduced 3.14%	3,855 $357,000
Q3 2019 Nov 14, 2019	SELL	$76.65 - $95.51 $79,716 - $99,330	-1,040 Reduced 20.72%	3,980 $305,000
Q2 2019 Aug 07, 2019	SELL	$54.2 - $85.95 $80,161 - $127,120	-1,479 Reduced 22.76%	5,020 $431,000
Q1 2019 May 14, 2019	BUY	$49.45 - $62.8 $321,375 - $408,137	6,499 New	6,499 $384,000
Q3 2018 Nov 14, 2018	SELL	$46.8 - $58.97 $1,778 - $2,240	-38 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$30.92 - $37.27 $494 - $596	16 Added 72.73%	38 $1,000
Q4 2017 Feb 14, 2018	BUY	$32.53 - $38.92 $715 - $856	22	22 $1,000

Others Institutions Holding RGEN

# of Institutions

495

Shares Held

57.6M

Call Options Held

75.6K

Put Options Held

521K

View Full List

About REPLIGEN CORP

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $7.37B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

More about RGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fifth Third Bancorp, based on Form 13F filings with the SEC.

News

Stay updated on Fifth Third Bancorp with notifications on news.

Account

Fifth Third Bancorp Repligen Corp Transaction History